Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (2): 116-118.
• Contents • Previous Articles Next Articles
HU Ping
Received:
2017-03-10
Revised:
2017-03-10
Online:
2017-02-20
Published:
2017-03-10
CLC Number:
HU Ping. Relationship between the Incidence of Adverse Reactions and Injection Mode on Patients First Given Low Molecular Weight Heparin[J]. Chinese Journal of Pharmacovigilance, 2017, 14(2): 116-118.
Add to citation manager EndNote|Ris|BibTeX
[1] 刘璠, 封辰叶, 刘廷威,等. 低分子肝素单药抗凝治疗癌症相关急性肺血栓栓塞症疗效和预后分析[J]. 中国全科医学, 2014, 17(4):422-424.. [2] 张菊霞, 韩琳, 温玉洁,等. 皮下注射低分子肝素时不同推注时间对皮下出血的影响[J]. 中华护理杂志, 2014, 49(2):233-235. [3] 赵滨, 李艳玲, 王立芹,等. 低分子肝素皮下注射时间和按压时间对不良反应的影响研究[J]. 中国全科医学, 2016, 19(9):1037-1041. [4] 李春蕊, 张雯, 樊碧发. 数字评分法(NRS)与口述评分法(VRS)在老年慢性疼痛患者中的比较[J]. 中国疼痛医学杂志, 2016, 22(9):683-686. [5] 高晓津, 杨进刚, 杨跃进,等. 中国急性心肌梗死患者心血管危险因素分析[J]. 中国循环杂志, 2015, 30(3):206-210. [6] 黎雪玲, 李醒三. 急性心肌梗死患者先用低分子肝素对溶栓效果的影响[J]. 中国老年学杂志, 2016, 36(10):687. [7] Pourghaznein T, Azimi A V, Jafarabadi M A. The effect of injection duration and injection site on pain and bruising of subcutaneous injection of heparin[J]. J Clin Nurs,2014, 23(7/8):1105-1113. [8] 李艳玲, 赵滨, 沙莎,等. 低分子肝素皮下注射持续时间的循证护理效果观察[J]. 中国全科医学, 2014, 17(21):2483-2485. [9] 李香花. 改良注射方法在减少注射低分子肝素钠引起皮下出血和疼痛中的效果观察[J]. 护理实践与研究, 2015, 12(9):110-111. [10] Balci Akpinar R, Celcbioglu A. Effect of injection duration on bruising associated with wubcutaneous heparin: a quasi-experimental within-subject design[J]. Clin Nurs Stud, 2013,1(4):36-44. [11] 李艳玲, 赵滨, 刘慧敏. 低分子肝素皮下注射持续时间对不良反应影响的Meta分析[J]. 中国实用护理杂志, 2014, 30(18): 59-62. |
[1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
[2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
[3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
[4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
[5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
[6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
[7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
[8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
[9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
[10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
[11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
[12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
[13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
[14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
[15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||